FMP
Zillow Group, Inc. Class C
Z
NASDAQ
Zillow Group, Inc., a digital real estate company, operates real estate brands on mobile applications and Websites in the United States. The company operates through three segments: Homes; Internet, Media & Technology; and Mortgages. The Homes segment is involved in resale of homes; and title and escrow services to home buyers and sellers, including title search procedures for title insurance policies, escrow, and other closing services. The IMT segment offers premier agent, rentals, and new construction marketplaces, as well as dotloop, display, and other advertising, as well as business software solutions. The Mortgage segment provides home loans; and marketing products including custom quote and connect services. Its portfolio of brands includes Zillow Rentals, Trulia, StreetEasy, Zillow Closing Services, HotPads, and Out East. The company was incorporated in 2004 and is headquartered in Seattle, Washington.
67.93 USD
0.03 (0.04416%)
Mr. Jeremy Wacksman
Communication Services
Internet Content & Information
NASDAQ
Zillow Group, Inc., a digital real estate company, operates real estate brands on mobile applications and Websites in the United States. The company operates through three segments: Homes; Internet, Media & Technology; and Mortgages. The Homes segment is involved in resale of homes; and title and escrow services to home buyers and sellers, including title search procedures for title insurance policies, escrow, and other closing services. The IMT segment offers premier agent, rentals, and new construction marketplaces, as well as dotloop, display, and other advertising, as well as business software solutions. The Mortgage segment provides home loans; and marketing products including custom qu...
0001617640
US98954M2008
98954M200
1301 Second Avenue
206 470 7000
US
6,856
Aug 3, 2015
0001617640
NASDAQ
Internet Content & I...
Communication Servic...
98954M200
US98954M2008
US
67.93
2.22
3.18M
16.35B
-
39.05-89.39
20.04
-
-
-
-
-141.52
-
https://www.zillowgroup.com
We are unable to load the data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Gordon Thompson
3 days ago
TransCode Therapeutics, Inc. (Nasdaq: RNAZ) is a biotechnology company that specializes in developing RNA-based therapies for cancer treatment. The company is set to undergo a significant change on May 15, 2025, with a 1-for-28 reverse stock split. This move is intended to consolidate 28 shares into one, affecting the trading dynamics of its stock. The reverse stock split, approved by TransCode's Board of Directors and stockholders on May 2, 2025, is a strategic decision aimed at increasing the...
Gordon Thompson
3 days ago
Papa John's stock price target has seen a downward trend, but UBS analyst Dennis Geiger offers a notably higher price target of $93. The company reported Q4 earnings of $0.63 per share, surpassing the Zacks Consensus Estimate. Despite a recent 8.1% surge in stock price, the trend in earnings estimate revisions may not support continued upward momentum. Papa John's International, Inc. (NASDAQ:PZZA) is a key player in the global pizza delivery and carryout industry. Founded in 1984 and headquar...
Gordon Thompson
3 days ago
ANZ Group, trading as ANZGY on the PNK exchange, is one of Australia's major banks, ranking as the fourth-largest in the country. The bank provides a wide range of financial services, including personal banking, business banking, and wealth management. ANZ faces competition from other major Australian banks like Commonwealth Bank, Westpac, and NAB. On May 7, 2025, ANZGY reported its earnings, revealing an earnings per share (EPS) of $0.777, which matched the estimated EPS. The company also repo...
Tony Dante
5 days ago
Citizens Financial Services Inc. (NASDAQ:CZFS) is a financial company based in Mansfield, known for its strong dividend offerings. On May 6, 2025, John P. Painter II, a director of the company, purchased 215 shares of its Common Class stock at $57.40 each. This transaction increased his total ownership to about 2,402 shares, indicating confidence in the company's performance. CZFS is recognized as a strong dividend stock, as highlighted by Zacks Investment Research. Dividends are a portion of a...
Danny Green
5 days ago
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is a global leader in musculoskeletal healthcare. The company designs, manufactures, and markets orthopedic reconstructive products, including knee and hip replacements, as well as other surgical and dental products. Zimmer Biomet competes with other major players in the medical device industry, such as Stryker Corporation and Johnson & Johnson. On May 6, 2025, Rick Wise from Stifel Nicolaus set a price target of $115 for Zimmer Biomet. At that time, the ...
Parth Sanghvi
5 days ago
After a steep pullback in AI-related equities so far in 2025, Wells Fargo’s Christopher Harvey argues that infrastructure and service providers—the “picks & shovels” of the AI revolution—are once again attractive. Here’s why investors may want to reenter this durable supercycle. YTD Drawdown Uncovers Compelling Value Harvey highlights that many AI-infrastructure names have been sold down sharply this year, creating entry points not seen since early 2024. With valuations resetting, the risk...
Stuart Mooney
6 days ago
The AZEK Company (NYSE:AZEK) is a leading manufacturer of building products, specializing in sustainable and innovative materials for outdoor living spaces. As a key player in the construction industry, AZEK competes with companies like Trex and Fiberon. The company is set to release its quarterly earnings on May 6, 2025, with analysts estimating earnings per share (EPS) of $0.44 and projected revenue of approximately $444.8 million. For the quarter ending March 2025, AZEK is expected to report...
Davit Kirakosyan
6 days ago
Zimmer Biomet (NYSE:ZBH) reported first-quarter results that came in ahead of Wall Street expectations, with gains in hip sales and stronger top-line performance. However, shares dropped more than 9% intra-day today on lowered guidance. The medical device maker posted adjusted earnings of $1.81 per share, beating the $1.77 consensus. Revenue grew 1.1% year-over-year to $1.91 billion, slightly topping the $1.89 billion estimate. Growth was supported by a 3.7% increase in U.S. hip sales, fueled b...